Eyal C. Attar, CHIEF MEDICAL OFFICER at Vor Biopharma Inc. (VOR), sold 14,645 shares at $1.39 ($20K) on 2024-06-03, disclosed to the SEC on 2024-06-04.
Scheduled sale ($20k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VOR | SELL | 2024-12-31 | $13K | — | Filing → |
| APRE | SELL | 2022-03-01 | $62K | — | Filing → |
| APRE | SELL | 2021-09-20 | $149K | — | Filing → |